Cannara is built for today, positioned for the future.

Cannara’s Farnham facility is a fully controlled environment that allows for efficient cultivation. Our approach will increase margins, accelerate speed to market and produce a premium product at low operating cost.

Financial Reports

MD&A Q4 and Year End 2019

Audited Consolidated Financial Statements year-ended Aug. 31, 2019 and 191-day period ended Aug. 31, 2019.

Q4 and Year-End Financial Statements 2019

Audited Consolidated Financial Statements year-ended Aug. 31, 2019 and 191-day period ended Aug. 31, 2019.

Financial Statements Q3 2019

Condensed Interim Consolidated Financial Statements. Three and six month periods ended May 31, 2019.

MD&A Q3 2019

Condensed Interim Consolidated Financial Statements. Three and six month periods ended May 31, 2019.

Financial Statements Q2 2019

Condensed Interim Consolidated Financial Statements. Three and six month periods ended February 28, 2019.

MD&A Q2 2019

Management Discussion and Analysis – February 28, 2019.

Press Releases

November 27, 2019

Cannara Biotech Reports Q4 and Year-End 2019 Financial Results

Cannara Biotech Inc. (“Cannara” or the “Company”) (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium cannabis and cannabis-infused products, today announced financial results for the three month period and year ended August 31, 2019.

October 10, 2019 

Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has secured a first mortgage against its Farnham Facility…

September 12, 2019

Cannara Biotech Submits Site Evidence Package to Health Canada
for its Quebec Facility

Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has submitted to Health Canada…

August 14, 2019

Cannara Announces Appointment of New Chief Operating Officer

Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried…

July 25, 2019

Cannara Biotech Inc. Reports Q3 2019 Results

Cannara Biotech (“Cannara” or the “Company”) (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products…

View More